Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Centers for Disease Control and Prevention - ERA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $365,000
- Closes
- Dec 8, 2026 (in 61 days)
Similar opportunities open now
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)OpenNational Institutes of HealthCloses Sep 2028
- INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jun 2028Up to $200K
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)OpenNational Institutes of HealthCloses Jan 2028
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jan 2028
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jan 2028
Classification and identifiers
- Solicitation number
- RFA-OH-26-015
- Assistance listing (CFDA)
- 93.262
Amount
$365,000
Who can apply
Small businesses, Nonprofits, including small and volunteer-run organizations, and State government agencies can all apply here. Check the eligibility details below to see if your organization fits.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
About this opportunity
The World Trade Center (WTC) Health Program supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty among individuals receiving monitoring and/or treatment under Subtitle C of the James Zadroga 9/11 Health and Compensation Act of 2010, as amended. This R21 Notice of Funding Opportunity (NOFO) is intended to encourage exploratory/developmental research by supporting the early and conceptual stages of project development to assess the feasibility of new areas of investigation with the potential to improve treatment effectiveness and diagnostic practices. These studies may lead to breakthroughs in a particular area or to the development of new interventions, techniques, agents, methodologies, models, or approaches with ...